Professor
John Hardy (UCL Institute of Neurology) comments on the trial of a new
Alzheimer's drug showing promising signs it could slow the early progression of
the disease.
Read: The Guardian,
More: BBC News,
International Business Times,
Toronto Star,
Daily Mail,
ITV News,
Mirror
Close
